Mirexus Biotechnologies Inc. Raises $12 Million to Finance Factory, Fund Business Development, and Deepen R&D

Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million.  Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherixTM, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health.  The funds will be used to finance a factory to produce PhytoSpherixTM, and to fund at least three years of operations as the company grows.  

As revenue grows, we believe the best path forward is to produce PhytoSpherix™ in our own factory here in Ontario – for sale around the world. This will allow us to produce high quality material under exacting manufacturing standards as we meet the needs of our growing customer base. We will build a first-of-a-kind plant using our own proprietary process that only uses water and energy to extract this natural nanomaterial from Ontario sweet corn. This facility keeps us right here in Guelph – close to abundant agricultural lands and the University of Guelph - where this technology was first developed
— Dr. Phil Whiting, Mirexus President and CEO

For the full press release click here